Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently bought shares of Mettler-Toledo International Inc. NYSE: MTD. In a filing disclosed on May 31st, the Representative disclosed that they had bought between $1,001 and $15,000 in Mettler-Toledo International stock on May 15th. The trade occurred in the Representative's "JP MORGAN BROKERAGE ACCOUNT" account.
Representative Robert Bresnahan, Jr. also recently made the following trade(s):
- Sold $1,001 - $15,000 in shares of Zimmer Biomet NYSE: ZBH on 5/15/2025.
- Sold $15,001 - $50,000 in shares of Elevance Health NYSE: ELV on 5/15/2025.
- Sold $15,001 - $50,000 in shares of PepsiCo NASDAQ: PEP on 5/15/2025.
- Sold $1,001 - $15,000 in shares of WEC Energy Group NYSE: WEC on 5/15/2025.
- Purchased $15,001 - $50,000 in shares of Advanced Micro Devices NASDAQ: AMD on 5/15/2025.
- Purchased $1,001 - $15,000 in shares of Hershey NYSE: HSY on 5/15/2025.
- Purchased $1,001 - $15,000 in shares of Kraft Heinz NASDAQ: KHC on 5/15/2025.
- Sold $1,001 - $15,000 in shares of Exxon Mobil NYSE: XOM on 5/15/2025.
- Sold $1,001 - $15,000 in shares of Danaher NYSE: DHR on 5/15/2025.
- Sold $1,001 - $15,000 in shares of International Flavors & Fragrances NYSE: IFF on 5/15/2025.
Mettler-Toledo International Stock Up 0.6%
Shares of MTD traded up $6.54 during midday trading on Wednesday, hitting $1,173.00. The company's stock had a trading volume of 273,755 shares, compared to its average volume of 183,882. Mettler-Toledo International Inc. has a one year low of $946.69 and a one year high of $1,546.93. The stock has a market capitalization of $24.38 billion, a price-to-earnings ratio of 28.94, a price-to-earnings-growth ratio of 3.30 and a beta of 1.40. The company's fifty day simple moving average is $1,092.21 and its two-hundred day simple moving average is $1,204.96.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, topping the consensus estimate of $7.90 by $0.29. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. The firm had revenue of $883.74 million during the quarter, compared to the consensus estimate of $876.61 million. During the same quarter in the previous year, the firm earned $8.89 earnings per share. The business's quarterly revenue was down 4.6% on a year-over-year basis. On average, research analysts predict that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.
Analyst Ratings Changes
Several equities research analysts recently weighed in on the company. Evercore ISI raised their price objective on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an "outperform" rating in a report on Monday, February 10th. Robert W. Baird dropped their target price on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating for the company in a research report on Tuesday, April 22nd. UBS Group raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and cut their price target for the company from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Jefferies Financial Group raised Mettler-Toledo International from an "underperform" rating to a "hold" rating and lowered their price objective for the company from $1,200.00 to $1,110.00 in a research note on Monday, May 5th. Finally, Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price objective for the company in a report on Monday, April 7th. Seven analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $1,302.11.
View Our Latest Stock Report on MTD
Insiders Place Their Bets
In other news, Director Michael A. Kelly sold 1,062 shares of Mettler-Toledo International stock in a transaction on Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the completion of the sale, the director now owns 120 shares in the company, valued at $139,191.60. The trade was a 89.85% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.94% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Mettler-Toledo International
Institutional investors have recently modified their holdings of the company. Vanguard Group Inc. raised its stake in Mettler-Toledo International by 1.2% during the first quarter. Vanguard Group Inc. now owns 2,543,365 shares of the medical instruments supplier's stock worth $3,003,485,000 after buying an additional 30,535 shares during the last quarter. Alliancebernstein L.P. raised its position in shares of Mettler-Toledo International by 21.6% in the 1st quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier's stock worth $837,653,000 after acquiring an additional 126,147 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of Mettler-Toledo International by 2.0% in the 4th quarter. Geode Capital Management LLC now owns 558,471 shares of the medical instruments supplier's stock valued at $682,340,000 after purchasing an additional 11,032 shares during the period. Price T Rowe Associates Inc. MD grew its stake in Mettler-Toledo International by 5.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier's stock worth $568,032,000 after purchasing an additional 25,272 shares during the period. Finally, T. Rowe Price Investment Management Inc. increased its holdings in Mettler-Toledo International by 11.9% in the first quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier's stock worth $479,673,000 after purchasing an additional 43,082 shares in the last quarter. 95.07% of the stock is owned by institutional investors.
About Representative Bresnahan
Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania's 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania's 8th Congressional District. He declared candidacy for the 2026 election.
Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.
About Mettler-Toledo International
(
Get Free Report)
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Featured Articles
Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
